Transplantation Proceedings

Preface
pp. 2387-2387(1)
Author: Jevnikar A.M.

A comparison between cyclosporine and tacrolimus-based immunosuppression for renal allografts: renal function and blood pressure after 5 years
pp. 2391-2394(4)
Authors: Muirhead N.; House A.; Hollomby D.J.; Jevnikar A.M.

Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients
pp. 2395-2397(3)
Authors: Singh D.; Kiberd B.A.; West K.A.; Kamal K.; Balbontin F.; Belitsky P.; Lawen J.

Long-term follow-up of pediatric en bloc renal transplantation
pp. 2398-2399(2)
Authors: Beasley K.A.; Balbontin F.; Cook A.; Bloch M.; McAlister V.C.; Lawen J.; Luke P.P.W.

Prevention of CAN graft loss in the medium term without HLA disparity reduction
pp. 2400-2402(3)
Authors: Baltzan M.A.; Shoker A.S.; Baltzan M.A.

Laparoscopic hand-assisted living donor nephrectomy: the Calgary experience
pp. 2403-2404(2)
Authors: Salazar A.; Yilmaz S.; Monroy M.; Sepandj F.; Tibbles L.; McLaughlin K.

Transplant Friends: an interactive education program for patients awaiting kidney transplantation
pp. 2405-2406(2)
Authors: Sharkey C.; Gourishankar S.

Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors
pp. 2407-2408(2)
Authors: Bunnapradist S.; Takemoto S.K.

Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantation
pp. 2409-2411(3)
Authors: Balbontin F.; Kiberd B.; Singh D.; Squires J.; Fraser A.; Belitsky P.; Lawen J.

Effect of valsartan on urinary protein excretion and renal function in patients with chronic renal allograft nephropathy
pp. 2412-2414(3)
Authors: Muirhead N.; House A.; Hollomby D.J.; Jevnikar A.M.

Renin-angiotensin system blockade in biopsy-proven allograft nephropathy
pp. 2415-2417(3)
Authors: Zaltzman J.S.; Nash M.; Chiu R.; Prasad G.V.R.

Mesh hood fascial closure in renal allograft compartment syndrome
pp. 2418-2419(2)
Authors: Beasley K.A.; McAlister V.C.; Luke P.P.W.

Ureteral implantation technique and urologic complications in adult kidney transplantion
pp. 2420-2422(3)
Authors: Tzimas G.N.; Hayati H.; Tchervenkov J.I.; Metrakos P.P.

MELD/PELD: one year later
pp. 2425-2427(3)
Author: Freeman R.B.

Transplantation in Canada: report of the Canadian Organ Replacement Register
pp. 2428-2430(3)
Authors: McAlister V.C.; Badovinac K.

Liver transplantation for primary sclerosing cholangitis
pp. 2431-2434(4)
Authors: Solano E.; Khakhar A.; Bloch M.; Quan D.; McAlister V.; Ghent C.; Wall W.; Marotta P.

Do biliary endoprostheses decrease biliary complications after liver transplantation?
pp. 2435-2437(3)
Authors: Barkun J.S.; Tzimas G.N.; Cantarovich M.; Metrakos P.P.; Deschenes M.; Alpert E.; Paraskevas S.; Tchervenkov J.I.

Survival after liver transplantation for hepatocellular carcinoma
pp. 2438-2441(4)
Authors: Khakhar A.; Solano E.; Stell D.; Bloch M.; Dale C.; Burns P.; Ghent C.; Quan D.; McAlister V.; Marotta P.; Wall W.J.

Tacrolimus monitoring by simplified sparse sampling under the concentration time curve
pp. 2445-2448(4)
Authors: Balbontin F.G.; Kiberd B.; Squires J.; Singh D.; Fraser A.; Belitsky P.; Lawen J.

Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report
pp. 2449-2451(3)
Authors: Bhaloo S.; Prasad G.V.R.

An evaluation of the activation of endogenous pancreatic enzymes during human islet isolations
pp. 2455-2457(3)
Authors: Rose N.L.; Palcic M.M.; Shapiro A.M.J.; Lakey J.R.T.

An evaluation of endogenous pancreatic enzyme levels following enzymatic digestion
pp. 2458-2460(3)
Authors: Rose N.L.; Palcic M.M.; Shapiro A.M.J.; Lakey J.R.T.

Resuscitation of the ischemically damaged human pancreas by the two-layer method prior to islet isolation
pp. 2461-2462(2)
Authors: Tsujimura T.; Kuroda Y.; Avila J.G.; Kin T.; Churchill T.A.; Shapiro A.M.J.; Lakey J.R.T.

Cardiac transplantation in the older recipient: excellent long-term survival based on pretransplant screening
pp. 2465-2467(3)
Authors: Baran D.A.; Galin I.D.; Courtney M.C.; Correa R.; Chan M.; Spielvogel D.; Lansman S.L.; Gass A.L.

Quality of life and function following cardiac transplantation in adolescents
pp. 2468-2470(3)
Authors: Pollock-BarZiv S.M.; Anthony S.J.; Niedra R.; Dipchand A.I.; West L.J.

The Alberta adult heart transplant experience: survival based on age, gender, etiology, ischemic times, bridge to transplant, and bicaval technique
pp. 2471-2474(4)
Authors: Wang S.; Halenar J.; Wildhirt S.M.; Johnston L.; Koshal A.; Mullen J.; Ross D.; Modry D.

Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival
pp. 2477-2478(2)
Authors: Nanji S.A.; Hancock W.W.; Anderson C.C.; Zhu L.F.; Kneteman N.M.; Shapiro A.M.J.

Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice
pp. 2479-2480(2)
Authors: Chen W.; Ford M.S.; Young K.J.; Zhang L.

Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury
pp. 2481-2482(2)
Authors: Du C.; Guan Q.; Yin Z.; Masterson M.; Zhong R.; Jevnikar A.M.

In vitro senescence occurring in normal human endothelial cells can be rescued by ectopic telomerase activity
pp. 2483-2485(3)
Authors: Young A.T.L.; Lakey J.R.T.; Murray A.G.; Mullen J.C.; Moore R.B.

Preface
pp. 2491-2491(1)
Author: Toro-Cornejo J.

Induction immunosuppressive therapy stratified according to risk categories in renal transplantation
pp. 2495-2499(5)
Authors: Troncoso P.; Ortiz A.M.; Jara A.

Clinical graft evolution of lymphocytes, polymorphonuclear cells, and antigen expression in tubular renal cells in the urine sediment of 20 renal allograft recipients
pp. 2500-2505(6)
Authors: Pefaur J.; Trivino R.; Navarrete C.; Oberhauser E.; Melys M.; Morales I.; Salinas P.; Mocarquer A.

Outcomes of orthotopic liver transplantation in Chile
pp. 2509-2510(2)
Authors: Buckel E.; Uribe M.; Brahm J.; Silva G.; Ferrario M.; Godoy J.; Segovia R.; Ceresa S.; Hunter B.; Alegria S.; Berwart F.; Smok G.; Herzog C.; Santander T.; Calabran L.

Epidemiology and results of liver transplantation for acute liver failure in Chile
pp. 2511-2512(2)
Authors: Uribe M.; Buckel E.; Ferrario M.; Godoy J.; Blanco A.; Hunter B.; Ceresa S.; Alegria S.; Cavallieri S.; Berwart F.; Smok G.; Herzog C.; Santander M.T.; Calabran L.

Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect
pp. 2515-2517(3)
Authors: Sauma D.; Fierro A.; Mora J.R.; Lennon-Dumenil A.M.; Bono M.R.; Rosemblatt M.; Morales J.

Basiliximab: efficacy and tolerability in adults and children
pp. 2518-2519(2)
Authors: Mocarquer A.; Pinto V.; Buckel E.; Lagos E.; Pefaur J.; Ramirez K.; Morales J.; Rosatti P.; Elberg A.; the Simulect Multicenter Study Group of Chile

IL-2 receptor blockers in liver transplantation: initial experience with daclizumab in Chile
pp. 2520-2521(2)
Authors: Innocenti F.; Humeres R.; Zamboni M.; Sanhueza E.; Zapata R.; Hepp J.; Rius M.

Ketoconazole alters cyclosporine pharmacokinetic profile and may predispose to acute rejection
pp. 2522-2523(2)
Authors: Dominguez J.; Kompatzki A.; Foradori A.; Norambuena R.

Preface
pp. 2529-2529(1)
Author: Shaheen F.A.M.

Transplant procurement management: a model for organ and tissue shortage
pp. 2533-2538(6)
Authors: Manyalich M.; Cabrer C.; Valero R.; Paredes D.; Navarro A.; Trias E.; Vilarrodona A.; Ruiz A.; Rodriguez C.; Paez G.

Should we have live unrelated donor transplantation in the MESOT countries? Islamic perspective
pp. 2539-2541(3)
Authors: Boobes Y.; Al Daker N.M.

Should we have live unrelated donor renal transplantation in MESOT countries?
pp. 2542-2544(3)
Author: Ghods A.J.

Intensive care unit nurses' attitudes and knowledge toward brain death and cadaveric renal transplantation in iran
pp. 2545-2545(1)
Authors: Nasrollahzadeh D.; Siavosh H.; Ghods A.J.

Transplant procurement management: 2680 seeds sowed in the field of transplantation
pp. 2546-2546(1)
Authors: Paez G.; Valero R.; Paredes D.; Cabrer C.; Navarro A.; Trias E.; Ruiz A.; Fatjo F.; Manyalich M.

Laparoscopic living donor nephrectomy in a center with limited laparoscopic experience
pp. 2549-2550(2)
Authors: Basiri A.; Ziaee S.A.M.; Hosseini Moghaddam S.M.M.; Maghsoodi R.; Shafi M.H.; Salim N.S.

Technical modifications of laparoscopic donor nephrectomy associated with improved graft quality and transplant outcome
pp. 2551-2551(1)
Authors: Khauli R.B.; Hussein M.; Madi R.; Shaar A.; Dagher F.J.

A prospective evaluation of laparoscopic donor nephrectomy versus open donor nephrectomy
pp. 2552-2552(1)
Authors: Khauli R.B.; Hussein M.; Shaar A.; Madi R.; Medawar W.; Habbal A.; Kazma A.; Dagher F.

Laparoscopic versus open live donor nephrectomy: the first randomized clinical trial
pp. 2553-2554(2)
Authors: Simforoosh N.; Bassiri A.; Ziaee S.A.M.; Tabibi A.; Salim N.S.; Pourrezagholi F.; Moghaddam S.M.M.H.; Maghsoodi R.; Shafi H.

A fast and safe living donor nephrectomy technique
pp. 2555-2556(2)
Authors: Hakim N.; Zarka Z.A.; El-Tayar A.; Mustafa N.; Papalois V.

Analysis of early complications of live donor nephrectomies
pp. 2557-2558(2)
Authors: Shamsa A.; Rasulian H.; Pourmahdi M.; Kadkhodayan A.; Yarmohammadi A.A.; Rezaee M.A.; Ahmadnia H.; Feiz Zadeh B.; Parizadeh M.R.

Gender disparity in a live donor renal transplantation program: assessing from cultural perspectives
pp. 2559-2560(2)
Authors: Ghods A.J.; Nasrollahzadeh D.

Living kidney donation-benefits of a follow up clinic
pp. 2561-2561(1)
Authors: Jawad F.; Zafar M.N.; Aziz T.; Khalid R.; Naqvi S.A.A.; Rizvi S.A.H.

High rate of primary function in 52 locally procured cadaveric kidneys in Kuwait
pp. 2562-2562(1)
Authors: Kumar A.; Al-Mousawi M.; Samahan M.; Dashti M.; Gawish A.; Nair M.P.; Nampoory M.R.N.; Johny K.V.

Sixteen hours of cold ischemia in living donor kidney transplantation
pp. 2563-2563(1)
Authors: Mohammadi A.; Yazdani M.; Ajudani T.; Adib M.

Effect of prolonged cold ischemia time on the outcome of cadaveric renal grafts
pp. 2564-2565(2)
Authors: Gencoglu E.A.; Ayaz S.; Moray G.; Emiroglu R.; Haberal M.

Antiinflammatory action of heparin via the complement system in renal ischemia-reperfusion
pp. 2566-2570(5)
Authors: Yagmurdur M.C.; Colak T.; Emiroglu R.; Karabay G.; Bilezikci B.; Turkoglu S.; Aldemir D.; Moray G.; Haberal M.

Living kidney donation for the mentally impaired. a case report
pp. 2571-2572(2)
Authors: Mohsin N.; Marhuby H.; Maimani Y.; Aghanishankar P.; Al-Hassani M.; Daar A.S.

Hepatitis C virus infection in hemodialysis patients from Tunisia: national survey by serologic and molecular methods
pp. 2573-2575(3)
Authors: Ayed K.; Gorgi Y.; Ben Abdallah T.; Aouadi H.; Jendoubi-Ayed S.; Sfar I.; Makni H.

High prevalence of hepatitis G virus infection in prospective transplant patients with hepatitis C infection
pp. 2576-2577(2)
Authors: Ayed K.; Gorgi Y.; Ben Abdallah T.

Complications and long-term follow-up of 4416 vascular access procedures
pp. 2578-2579(2)
Authors: Basaran O.; Karakayali H.; Emiroglu R.; Belli S.; Haberal M.

Study of the relationship between oral Candida colony counts and time on hemodialysis at Khorshid Hospital, Isfahan, Iran
pp. 2580-2581(2)
Authors: Yazdani M.; Jahanshahi G.R.; Mahdavi K.N.; Asadian F.

Causes of elimination of hemodialysis patients from renal transplantation list in Iran
pp. 2582-2583(2)
Authors: Argani H.; Tehrani S.

Characteristics of hemodialysis patients who underwent renal transplantation in Tehran, Iran: a 10-year follow-up study
pp. 2584-2585(2)
Authors: Haghighi A.N.; Rahbar K.; Fasihi F.; Malakoutian T.; Haghighi N.N.; Haghighi E.N.; Nowroozi A.

Evaluation of peripheral and central nerve integrity in hemodialysis and renal transplantation
pp. 2586-2587(2)
Authors: Argani H.; Toopchizadeh V.; Sadighmostophi M.; Anami A.

Bladder neck obstruction due to bilharzial cystitis as a cause of renal failure in Aden City
pp. 2588-2589(2)
Authors: Al Kaff H.M.; Bawazir A.A.

Chronic renal failure in children
pp. 2590-2591(2)
Authors: Derakhshan A.; Hashemi G.H.; Fallahzadeh M.H.

Effect of HMG-CoA reductase inhibitors on reduction of panel reactivity
pp. 2592-2593(2)
Authors: Ossareh S.; Ghorbani G.; Ghods A.J.

Three hundred one cases of renal transplantation from Tabriz, Iran
pp. 2594-2595(2)
Authors: Khosroshahi H.T.; Mortazavi M.; Argani H.; Bohloli A.; Mirzai A.

Renal transplantation at Saudi Aramco
pp. 2596-2597(2)
Authors: Alkhunaizi A.M.; Amir A.; Yousif B.

Is preemptive renal transplantation preferred?
pp. 2598-2601(4)
Authors: Simforoosh N.; Basiri A.; Pourrezagholi F.; Einolahi B.; Firouzan A.; Moghaddam M.M.; Nourbala M.H.; Hajarizadeh B.; Pourfarziani V.; Lessanpezeshki M.; Nafar M.; Khatami M.R.; Moghaddam S.M.M.H.; Farhangi S.

Influence of recipient family history of atherosclerosis of renal allograft outcome
pp. 2602-2604(3)
Authors: Ozdemir F.N.; Canturk F.; Colak T.; Sezer S.; Agca E.; Haberal M.

Patient and graft outcome after living donor renal transplantation in Iran: more than 15-year follow-up
pp. 2605-2606(2)
Authors: Einollahi B.; Hajarizadeh B.; Simforoosh N.; Lessanpezeshki M.; Khatami M.R.; Nourbala M.H.; Basiri A.; Pourfarziani V.; Firoozan A.; Nafar M.; Poorrezagholi F.; Sharifian M.; Bakhtiari S.; Alavian S.M.

Do serum albumin and aminotransferase levels predict renal graft outcome: a 5-year follow-up
pp. 2607-2608(2)
Authors: Sezer S.; Ozdemir F.N.; Kulah E.; Colak T.; Turan M.; Haberal M.

Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients
pp. 2609-2611(3)
Authors: Ghods A.J.; Nasrollahzadeh D.; Argani H.

More urine is better after renal transplantation
pp. 2612-2613(2)
Authors: Ardalan M.R.; Argani H.; Mortazavi M.; Tayebi H.; Abedi A.S.; Toluey M.

Ramadan fast in kidney transplant recipients: a prospective comparative study
pp. 2614-2616(3)
Authors: Said T.; Nampoory M.R.N.; Haleem M.A.; Nair M.P.; Johny K.V.; Samhan M.; Al-Mousawi M.

Renal transplantation for Takayasu's Arteritis: a case report
pp. 2617-2618(2)
Authors: Basri N.A.; Shaheen F.A.M.

Development of morbid obesity after transplantation in Laurence Moon Biedle syndrome
pp. 2619-2619(1)
Authors: Mohsin N.; Marhuby H.; Maimani Y.; Aghanishankar P.; Al-Hassani M.; Seth M.; Daar A.S.

Scintigraphic assessment of the influence of recipient age on the outcome of renal transplantation
pp. 2620-2622(3)
Authors: Gencoglu E.A.; Ayaz S.; Moray G.; Emiroglu R.; Haberal M.

Magnetic resonance angiography findings in renal transplant recipients
pp. 2623-2624(2)
Authors: Malvathu R.; Jain R.; Jha A.; Kallankara S.; Asif P.; Mohsin N.

Classification of Tc-99m DTPA perfusion time-activity curves in renal transplant recipients
pp. 2625-2627(3)
Authors: Aktas A.; Yalcin H.; Koyuncu A.; Haberal M.

Relation between resistive index and serum creatinine level in first month after renal transplantation
pp. 2628-2629(2)
Authors: Ardalan M.R.; Tarzamani M.K.; Mortaazavi M.; Bahloli A.

The value of quantitative Tc-99m diethylenetriamine pentaacetic acid scintigraphy for assessing pediatric renal transplant recipients
pp. 2630-2633(4)
Authors: Gencoglu E.A.; Moray G.; Karakayali H.; Emiroglu R.; Haberal M.

Assessment of risk factors for chronic allograft nephropathy in renal transplant patients
pp. 2634-2636(3)
Authors: Sezer S.; Ozdemir F.N.; Agca E.; Colak T.; Arat Z.; Haberal M.

Contribution of late acute rejection to long-term renal allograft survival in patients with chronic allograft nephropathy
pp. 2637-2638(2)
Authors: Sezer S.; Ozdemir F.N.; Akcay A.; Colak T.; Kut A.; Haberal M.

Early detection of amyloidosis in renal allografts: electron microscopic, histochemical, immunohistochemical findings and relationship with graft survival
pp. 2639-2640(2)
Authors: Ozdemir B.H.; Karabay G.; Ozdemir F.N.; Demirhan B.; Haberal M.

Beneficial effect of enalapril on slowing the progression of chronic renal allograft dysfunction
pp. 2641-2642(2)
Authors: Ghods A.J.; Ossareh S.

Significance of peritubular capillary basement membrane multilamellation in diagnosis of chronic allograft nephropathy
pp. 2643-2644(2)
Authors: Kiyici H.; Demirhan B.; Ozdemir B.H.; Aktas G.; Karabay G.; Haberal M.

Post-renal transplantation hypophosphatemia
pp. 2645-2646(2)
Authors: Seifi S.; Pezeshki M.L.; Khatami M.R.; Mazdeh M.M.; Ahmadi F.; Maziar S.

Impact of atenolol consumption on the development of chronic renal allograft dysfunction
pp. 2647-2649(3)
Authors: Jahromi A.R.H.; Raissjalali G.A.

Seasonal variation of blood pressure in renal transplant recipients
pp. 2650-2651(2)
Authors: Argani H.; Javanshir M.R.

Hypomagnesemia as a cause of severe cardiac arrythmias in the immediate postoperative period: a renal transplant case report
pp. 2652-2652(1)
Authors: Mohsin N.; Jha A.; Al Maimani Y.; Malvathu R.; Kallankara S.

Ureterocystoplasty and renal transplantation
pp. 2653-2654(2)
Authors: Zafarghandi R.M.; Ghorbani H.

Early common surgical complications in 1500 kidney transplantations
pp. 2655-2656(2)
Authors: Kamali K.; Zargar M.A.; Zargar H.

Major postoperative complications of renal transplantation: results from a single center in Turkey
pp. 2657-2659(3)
Authors: Karakayah H.; Basaran O.; Moray G.; Emiroglu R.; Haberal M.

Renal transplantation and ureteroneocystostomy (living and cadaveric donor)
pp. 2660-2661(2)
Authors: Taghavi R.; Zafarghandi R.M.; Darabi M.R.

Evaluation of urologic complications in 30 cases of kidney transplantation with technique of proper exposure edge of bladder mucosa and U-stitch ureteroneocystostomy
pp. 2662-2663(2)
Authors: Zomorrodi A.; Bahluli A.

Efficacy of extravesical ureteral reimplant and routine stenting in renal transplantation
pp. 2664-2664(1)
Author: Khauli R.B.

Removal of dysfunctioning ureteral stents with fluoroscopically guided percutaneous antegrade technique in renal transplant patients
pp. 2665-2667(3)
Authors: Aytekin C.; Boyvat F.; Colak T.; Emiroglu R.; Haberal M.

One center's experience with allograft nephrectomy
pp. 2668-2669(2)
Authors: Emiroglu R.; Sevmis S.; Moray G.; Karakayali H.; Bilgin N.; Yagmurdur M.C.; Haberal M.

Percutaneous drainage of perirenal abscess after kidney transplantation: a 4-year experience
pp. 2670-2671(2)
Authors: Ahmadnia H.; Yarmohamadi A.

Hypoesthesia of the thigh following renal transplantation
pp. 2672-2672(1)
Authors: Zargar M.A.; Darvishi A.; Shadpour P.; Shooshtari H.Z.

Serum albumin and lymphocyte subsets as predictors of infection in renal transplant patients
pp. 2673-2675(3)
Authors: Akman B.; Ozdemir F.N.; Colak T.; Haberal A.; Arat Z.; Haberal M.

Tuberculosis in organ transplant recipients
pp. 2676-2677(2)
Authors: Chugh K.S.; Jha V.

Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report
pp. 2678-2679(2)
Authors: Skhiri H.; Guedri Y.; Souani Y.; Achour A.; Bouraoui S.; Frih A.; Dhia B.N.; Elmay M.

Tuberculosis in renal transplant recipients
pp. 2680-2681(2)
Authors: Arslan H.; Ergin F.; Oner-Eyuboglu F.; Akcay S.; Karakayali H.; Haberal M.

Tuberculosis in renal transplant recipients
pp. 2682-2683(2)
Authors: Dridi A.; Kaaroud H.; Boubaker K.; Abdallah T.B.; EI-Younsi F.; Moussa F.B.; Hidri H.; Abderrahim E.; Khedher A.; Ben Maiz H.

Postrenal transplantation urinary tract infections
pp. 2684-2684(1)
Authors: Naghibi M.; Nazemian F.

Urinary tract infections in renal transplant recipients
pp. 2685-2686(2)
Authors: Ergin F.; Arslan H.; Yapar G.; Karakayali H.; Haberal M.

Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients
pp. 2687-2688(2)
Authors: Alavian S.M.; Hajarizadeh B.; Einollahi B.

Invasive pulmonary fungal infections in solid organ transplant recipients: a four-year review
pp. 2689-2691(3)
Authors: Oner-Eyuboglu F.; Karacan O.; Akcay S.; Arslan H.; Demirhan B.; Haberal M.

Obstructive anuria due to fungal bezoars in a renal graft recipient
pp. 2692-2693(2)
Authors: Kamel G.; Stephan A.; Barbari A.; Kilani H.; Karam A.; Zeineh S.; Salmeh P.; Husni R.; Mokhbat J.; Khoury J.

Resolution of pulmonary and cerebral nocardiosis in renal transplant patient despite continued immunosuppression: a case report
pp. 2694-2695(2)
Authors: Mooraki A.; Jenabi A.; Bastani B.

Incidence of bacterial vaginosis in renal transplant recipients
pp. 2696-2697(2)
Authors: Demirbilek M.; Can F.; Gulec A.T.; Kuscu E.; Kayhan Z.; Haberal M.

Brucellosis arthritis-a rare complication of renal transplantation: a case report
pp. 2698-2698(1)
Authors: Einollahi B.; Hamedanizadeh A.K.; Alavian S.M.

Impact of hepatitis C virus infection on short-term outcome in renal transplantation: a single-center study
pp. 2699-2700(2)
Authors: Sabet S.; Hakemi M.; Nadjafi I.; Ganji M.R.; Argani H.; Broumand B.

HCV antibody positivity significantly affects renal allograft survival
pp. 2701-2702(2)
Authors: Ozdemir F.N.; Micozkadioglu H.; Sezer S.; Arat Z.; Gursoy M.; Boyacioglu S.; Haberal M.

Determination of antibodies to Toxoplasma gondii and CMV in renal transplant recipients
pp. 2703-2705(3)
Authors: Iqbal J.; Nampoory M.R.N.; Johnv K.V.; Khalid N.; Al-Mousawi M.

Intestinal perforation following renal transplantation: report of 2 cases related to cytomegalovirus disease
pp. 2706-2707(2)
Authors: Abderrahim E.; Bouhamed L.; Raies L.; Abdallah T.B.; Hedri H.; Barbouch S.; Maiz H.B.

Anti-cd20 antibodies to treat lymphoproliferative syndromes following renal transplantation
pp. 2708-2709(2)
Authors: Abderrahim E.; Karoui C.; Smaoui W.; Raies L.; Ben Abdallah T.; Hedri H.; Ben Moussa F.; Bardi R.; Ayed K.; Maiz H.B.

Malignancies in kidney transplant recipients: 13 years of experience
pp. 2710-2711(2)
Authors: Bahador A.; Hosseini S.A.M.; Salahi H.; Jalali G.A.R.; Behzadi S.; Davari H.R.; Javid R.; Janghorban P.

Evaluation and treatment of biliary lithiasis in renal transplantation candidates
pp. 2712-2713(2)
Authors: Moray G.; Basaran O.; Karakayali H.; Yagmurdur M.C.; Bilgin N.; Haberal M.

Effect of renal transplantation on left ventricular hypertrophy
pp. 2714-2715(2)
Authors: Azar S.A.; Ghods A.J.

Predictors of hematopoietic response after renal transplantation
pp. 2716-2717(2)
Authors: Arat Z.; Sezer S.; Ozdemir F.N.; Uyar M.; Turan M.; Haberal M.

Efficacy of hemodialysis and renal transplantation on reproductive function in men with end stage renal disease
pp. 2718-2719(2)
Authors: Kheradmand A.R.; Javadneia A.H.

Menstrual problems among kidney transplant recipients
pp. 2720-2721(2)
Authors: Ghazizadeh S.; Lessan-Pezeshki M.; Mahdavi M.; Razeghi E.; Seifi S.

Taste sense and serum zinc in renal transplantation
pp. 2722-2723(2)
Authors: Argani H.; Tabrizi A.; Ahamadi M.; Hassanzadeh H.

Bone loss in the early period after renal transplantation
pp. 2724-2724(1)
Authors: Hakemi M.; Ganji M.R.; Najafi I.

Evaluation of biochemical and immunologic changes in renal transplant recipients during ramadan fasting
pp. 2725-2726(2)
Authors: Argani H.; Mozaffari S.; Rahnama B.; Rahbani M.; Rejaie M.; Ghafari A.

A comparison between the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingival overgrowth in kidney transplant patients
pp. 2727-2728(2)
Authors: Nafar M.; Ataie R.; Einollahi B.; Nematizadeh F.; Firoozan A.; Poorrezagholi F.

Intraoperative anti-thymocyte globulin-fresenius bolus induction therapy in kidney transplantation
pp. 2729-2730(2)
Authors: Abou-Jaoude M.M.; Ghantous I.; Najm R.; Afif C.; Almawi W.Y.

Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients
pp. 2731-2732(2)
Authors: Abou-Jaoude M.M.; Ghantous I.; Najm R.; Afif C.; Almawi W.Y.

Acute kidney allograft rejection while on anti-thymocyte globulin induction: sequelae of pretransplant Alpha-Interferon treatment - a case report
pp. 2733-2734(2)
Authors: Halim M.A.; Nampoory M.R.N.; Said T.; Hamid M.H.; Nair M.P.; Samhan M.; Al-Mousawi M.; Al-Ali F.; Johny K.V.

Effect of daclizumab (Zenapax) on prevention of acute rejection of renal transplantation
pp. 2735-2736(2)
Authors: Poorrezagholi F.; Einollahi B.; Firoozan A.; Nafar M.; Yadegari H.; Moghaddam S.M.M.H.; Simforoosh N.; Basiri A.; Farhangi S.

Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients
pp. 2737-2738(2)
Authors: Shah M.H.; Bokhari M.Z.M.; Bokhari M.T.M.; Farooq A.; Yousaf S.M.

Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients
pp. 2739-2741(3)
Authors: Mehrsai A.R.; Pourmand G.; Mansour D.; Zand S.; Rezaali A.

Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy
pp. 2742-2744(3)
Authors: Barbari A.; Stephan A.; Masri M.; Mourad N.; Kamel G.; Kilani H.; Karam A.; Daya I.A.

The role of generics in transplantation
pp. 2745-2747(3)
Authors: Masri M.A.; Andrysek T.; Matha V.

Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients
pp. 2748-2749(2)
Authors: Abou-Jaoude M.M.; Irani-Hakime N.; Ghantous I.; Najm R.; Afif C.; Almawi W.Y.

Low-dose sirolimus in combination with mycophenolate in calcineurin inhibitor elimination: the Kuwaiti experience
pp. 2750-2751(2)
Authors: Johny K.V.; Nampoory M.R.N.; Hamid M.H.; Nair M.P.; Samhan M.; Al-Moussawi M.

Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation
pp. 2752-2753(2)
Authors: Taheri M.; Pourmand G.; Mehrsai A.R.; Mansoori D.

Rapid resolution of mycophenolate associated diarrhea with a small dose of octreotide: a case report
pp. 2754-2754(1)
Authors: Mohsin N.; Jha A.; Kallankara S.; Asif P.; Malvathu R.

Technical limitations of immunosuppressive drug therapy blood level monitoring
pp. 2755-2756(2)
Authors: Masri M.A.; Rizk S.; Kamel G.; Barbari A.; Stephan A.

Complete reversal of an acute rejection treated for 4 months after resuming dialysis: a case report
pp. 2757-2758(2)
Authors: Mohsin N.; Jha A.; Malvathu R.; Kallankara S.; Date A.; Mourad G.

Plasmapheresis in renal transplant patients: a single-center experience
pp. 2759-2760(2)
Authors: Basri N.; Shaikh I.; Shaheen F.A.M.

Outcome of 18 cases of simultaneous kidney and donor-specific bone marrow transplantation
pp. 2761-2762(2)
Authors: Ebrahimi-Rad M.; Nikbin B.; Mehrsai A.; Pourmand G.

Liver biopsy is mandatory to choose suitable liver grafts
pp. 2765-2767(3)
Authors: Emiroglu R.; Basaran O.; Yagmurdur M.C.; Boyacioglu S.; Bilezikci B.; Haberal M.

Donor safety and quality of life after left hepatic lobe donation in living-donor liver transplantation
pp. 2768-2769(2)
Authors: Basaran O.; Karakayali H.; Emiroglu R.; Tezel E.; Moray G.; Haberal M.

Exposure for hepatobiliary operations: a new incision
pp. 2770-2771(2)
Authors: Haberal M.; Emiroglu R.; Karakayali H.; Moray G.; Arslan G.; Yagmurdur M.C.; Bilgin N.

Living donor and split-liver transplantation: an overview
pp. 2772-2774(3)
Authors: Abouljoud M.; Yoshida A.; Dagher F.; Moonka D.; Brown K.

Preliminary report on continous cold perfusion during vascular anastomosis in liver transplantation
pp. 2775-2776(2)
Authors: Haberal M.; Emiroglu R.; Karakayali H.; Moray G.; Arslan G.; Bilgin N.; Demirhan B.

Long-term outcome after liver transplantation in Egyptians transplanted for hepatitis C virus cirrhosis
pp. 2777-2778(2)
Author: Khalaf H.

Liver transplantation in Iran
pp. 2779-2780(2)
Authors: Malek Hoseini S.A.; Bahador A.; Salahi H.; Davari H.R.; Lahsaee M.; Saberfiroozi M.H.; Bagheri M.M.; Haghighat M.

Starting the liver transplant program at King Faisal Specialist Hospital and Research Center in Saudi Arabia: early experience and future expectations
pp. 2781-2782(2)
Authors: Al-Sebayel M.; Khalaf H.

Living related liver transplantation in Egypt: an emerging program
pp. 2783-2786(4)
Authors: El-Meteini M.; Fayez A.; Fathy M.; Abdalaal A.; Safaan H.; Mostafa I.; Abdalaal M.; Syam M.; Refay R.; Abou-Alfetouh F.; Khedr H.; El-Halafawy Y.; Taher Y.; Hamed H.; Badawy S.; Ryad A.; Awad H.; Abdallah A.; Ghafar T.A.; El-Monayeri M.; Hoballah A.; El-Dorry A.; Adham M.; Boillot O.

Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity
pp. 2787-2788(2)
Authors: Khalaf H.; Al-Asseri A.; Bhuiyan J.; Nafea O.; Al-Sebayel M.

Surgical complications after liver transplantation in 67 Egyptian recipients
pp. 2789-2790(2)
Author: Khalaf H.

Diagnostic and therapeutic management of hepatic artery thrombosis and stenosis after orthotopic and heterotopic liver transplantation
pp. 2791-2795(5)
Authors: Boyvat F.; Aytekin C.; Firat A.; Harman A.; Karakayali H.; Haberal M.

Safe and fast techniques of bench work to prepare a pancreatic graft
pp. 2799-2800(2)
Authors: Hakim N.S.; Zarka Z.A.; El-Tayar A.; Mustafa N.; Papalois V.

Pancreatic transplantation for patients with type 1 diabetes
pp. 2801-2802(2)
Author: Hakim N.S.

A new technique for kidney-pancreas transplantation
pp. 2803-2804(2)
Authors: Hakim N.S.; Zarka Z.A.; El-Tayar A.; Mustafa N.; Papalois V.E.

A retrospective analysis of extracorporel membrane oxygenation versus right ventricular assist device in acute great failure after heart transplantation
pp. 2805-2807(3)
Authors: Taghavi S.; Ankersmit J.; Zuckermann A.; Roth G.A.; Wieselthaler G.; Rajek A.; Wolner E.; Grimm M.

Age-related alterations of oxidative stress and arginase activity as a response to intestinal ischemia-reperfusion in rat kidney and liver
pp. 2811-2815(5)
Authors: Aldemir D.; Tufan H.; Tecder-Unal M.; Turkoglu S.; Ogus E.; Kayhan Z.; Haberal M.

Comparison of two different liver storage techniques in rat liver model
pp. 2816-2820(5)
Authors: Basaran O.; Emiroglu R.; Karakayali H.; Moray G.; Bilgin N.; Yagmurdur M.C.; Ozdemir H.; Haberal M.

Xenotransplantation: recent scientific developments and continuing ethical discourse
pp. 2821-2822(2)
Author: Daar A.S.

Posttransfusion graft-versus-host disease in an infant with severe combined immunodeficiency
pp. 2825-2826(2)
Authors: Rahiminejad M.S.; Kashef S.

Potential applications of embryonic stem cells in organ transplantation
pp. 2827-2829(3)
Authors: Zou G.M.; Zavazava N.

Author index
pp. 2830-2832(3)